MarketBrief


914 stories

Source Document

All

SEC Filing Type

All
4 485
Insider Trading
8-K 134
Events or Changes Between Quarterly Reports
10-Q 28
Quarterly Reports
SC 13G/A 18
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions (Amendment)
10-K 10
Annual Reports
DEF 14A 10
Definitive proxy statements
SC 13G 10
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
3 7
Insider Trading (Form 3)
ARS 7
Annual Report to Security Holders
CT ORDER 7
CT ORDER Filing
DEFA14A 6
DEFA14A Filing
SC TO-I/A 5
Issuer tender offer statement (Amendment)
UPLOAD 5
UPLOAD Filing
424B3 4
Prospectus
CORRESP 4
Correspondence
S-8 4
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
10-K/A 3
Annual Report (Ammendment)
4/A 3
Insider Trading (Form 4) Amendment
424B5 3
Prospectus
8-K/A 3
Events or Changes Between Quarterly Reports
5 2
Insider Trading (Form 5)
SC TO-C 2
Written communication relating to an issuer or third party tender offer

  1. Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine

    PR Newswire 5-21-2013

    PARIS and TARRYTOWN, N.Y., May 21, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the New England Journal of Medicin...

  2. Regeneron Pharmaceuticals Inc Files 8-K : Entry into a Material Definitive Agreement, ...

    SEC Filing 5-20-2013

    Regeneron Pharmaceuticals Inc, based in TARRYTOWN, NY, filed an 8-K statement with the U.S. Securities Exchange Commission today.

  3. $4.1M of REGN sold by Michael Brown between 05/15/2013 - 05/17/2013

    SEC Filing 5-17-2013

    Brown Michael S sold 15,000 shares of Regeneron Pharmaceuticals Inc stock, or $4,127,920 worth, as noted in an SEC Filing today. As reported in the filing, the transactions occurred between May 15, 2013 - May 17, 2013. After the transaction, Brown Michael S's stake was reported as 14,662 shares of Regeneron Pharmaceuticals Inc stock. In addition, Brown Michael S performed several other transactions, including using transaction codes 'M' (exercise, usually of options).

  4. Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)

    PR Newswire 5-15-2013

    PARIS and TARRYTOWN, N.Y., May 15, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the COMPARE and ASCERTAIN tri...

  5. $6.4M of REGN sold by Neil Stahl on 05/13/2013

    SEC Filing 5-14-2013

    Stahl Neil sold 23,038 shares of Regeneron Pharmaceuticals Inc stock, or $6,378,806 worth, as noted in an SEC Filing today. As reported in the filing, the transactions occurred on May 13, 2013. After the transaction, Stahl Neil's stake was reported as 48,988 shares of Regeneron Pharmaceuticals Inc stock. In addition, Stahl Neil performed several other transactions, including using transaction codes 'M' (exercise, usually of options).

  6. $1.4M of REGN sold by George Sing on 05/10/2013

    SEC Filing 5-10-2013

    Sing George L sold 5,000 shares of Regeneron Pharmaceuticals Inc stock, or $1,350,000 worth, as noted in an SEC Filing today. As reported in the filing, the transactions occurred on May 10, 2013. After the transaction, Sing George L's stake was reported as 112,772 shares of Regeneron Pharmaceuticals Inc stock. In addition, Sing George L performed several other transactions, including using transaction codes 'M' (exercise, usually of options).

  7. $2.2M of REGN sold by Robert Terifay on 05/08/2013

    SEC Filing 5-09-2013

    Terifay Robert J sold 8,231 shares of Regeneron Pharmaceuticals Inc stock, or $2,150,192 worth, as noted in an SEC Filing today. As reported in the filing, the transactions occurred on May 8, 2013. After the transaction, Terifay Robert J's stake was reported as 15,324 shares of Regeneron Pharmaceuticals Inc stock. In addition, Terifay Robert J performed several other transactions, including using transaction codes 'M' (exercise, usually of options).

  8. $2.1M of REGN sold by Michael Aberman on 05/06/2013

    SEC Filing 5-08-2013

    Aberman Michael S sold 8,334 shares of Regeneron Pharmaceuticals Inc stock, or $2,142,927 worth, as noted in an SEC Filing today. As reported in the filing, the transactions occurred on May 6, 2013. After the transaction, Aberman Michael S's stake was reported as 11,700 shares of Regeneron Pharmaceuticals Inc stock. In addition, Aberman Michael S performed several other transactions, including using transaction codes 'M' (exercise, usually of options).

  9. $26.3M of REGN sold by George Yancopoulos on 05/07/2013

    SEC Filing 5-08-2013

    Yancopoulos George sold 100,000 shares of Regeneron Pharmaceuticals Inc stock, or $26,263,581 worth, as noted in an SEC Filing today. As reported in the filing, the transactions occurred on May 7, 2013. After the transaction, Yancopoulos George's stake was reported as 1,106,395 shares of Regeneron Pharmaceuticals Inc stock. In addition, Yancopoulos George performed several other transactions, including using transaction codes 'M' (exercise, usually of options).

  10. $3.5M of REGN sold by Vagelos P Roy on 05/06/2013

    SEC Filing 5-08-2013

    Vagelos P Roy sold 13,482 shares of Regeneron Pharmaceuticals Inc stock, or $3,548,550 worth, as noted in an SEC Filing today. As reported in the filing, the transactions occurred on May 6, 2013. After the transaction, Vagelos P Roy's stake was reported as 114,018 shares of Regeneron Pharmaceuticals Inc stock.

  11. $3.6M of REGN sold by Van Plew Daniel P on 05/07/2013

    SEC Filing 5-08-2013

    Van Plew Daniel P sold 13,725 shares of Regeneron Pharmaceuticals Inc stock, or $3,590,637 worth, as noted in an SEC Filing today. As reported in the filing, the transactions occurred on May 7, 2013. After the transaction, Van Plew Daniel P's stake was reported as 10,736 shares of Regeneron Pharmaceuticals Inc stock. In addition, Van Plew Daniel P performed several other transactions, including using transaction codes 'M' (exercise, usually of options).

  12. $3.5M of REGN sold by Marc Tessier-lavigne on 05/06/2013

    SEC Filing 5-08-2013

    Tessier-lavigne Marc sold 13,334 shares of Regeneron Pharmaceuticals Inc stock, or $3,478,942 worth, as noted in an SEC Filing today. As reported in the filing, the transactions occurred on May 6, 2013. In addition, Tessier-lavigne Marc performed several other transactions, including using transaction codes 'M' (exercise, usually of options).

  13. $7.8M of REGN sold by Eric Shooter on 05/06/2013

    SEC Filing 5-08-2013

    Shooter Eric M sold 30,000 shares of Regeneron Pharmaceuticals Inc stock, or $7,806,872 worth, as noted in an SEC Filing today. As reported in the filing, the transactions occurred on May 6, 2013. After the transaction, Shooter Eric M's stake was reported as 2,500 shares of Regeneron Pharmaceuticals Inc stock. In addition, Shooter Eric M performed several other transactions, including using transaction codes 'M' (exercise, usually of options).

  14. $7.8M of REGN sold by Alfred Gilman on 05/06/2013

    SEC Filing 5-08-2013

    Gilman Alfred G sold 30,000 shares of Regeneron Pharmaceuticals Inc stock, or $7,831,302 worth, as noted in an SEC Filing today. As reported in the filing, the transactions occurred on May 6, 2013. In addition, Gilman Alfred G performed several other transactions, including using transaction codes 'M' (exercise, usually of options).

  15. Regeneron Announces Upcoming 2013 Investor Conference Presentations

    PR Newswire 5-08-2013

    TARRYTOWN, N.Y., May 8, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences: UBS Global Healthcare C...

 
View More >


Corporate Filings
Other Documents
About